Eiichiro Satake

11PUBLICATIONS
63CO-AUTHORS
Nutrigenomics and personalised nutritionPredictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Epigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 10, 2025
Joslin Kidney Panel of Circulating Proteins: A Tool for ESKD Risk Discrimination and Individualized Diabetic Kidney Disease Treatment.

Andrzej S Krolewski, Jani K Haukka, Zaipul I Md Dom

|Aug 07, 2025
Urinary Complement proteome strongly linked to diabetic kidney disease progression.

Zaipul I Md Dom, Salina Moon, Eiichiro Satake

|Oct 31, 2024
Classification of Predictors of Rapid Development of Kidney Failure and Short-Term Changes in Concentration of Circulating Proteins.

Hiroki Kobayashi, Helen C Looker, Katsuhito Ihara

|May 22, 2024
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes.

Zhuo Chen, Eiichiro Satake, Marcus G Pezzolesi

|Aug 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Hiroki Kobayashi, Helen C Looker, Eiichiro Satake

|Jul 15, 2021
Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (<i>HSD17B14</i>) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes.

Josyf C Mychaleckyj, Erkka Valo, Takaharu Ichimura

Pageof 2